FEMY Latest Press Releases

-- October 30, 2026 --

Femasys Appoints John Moorhead to Board of Directors Globe Newswire 9:00 AM

-- October 20, 2026 --

Femasys Partners with SandsRx Pharmacy to Support FemaSeed Fertility Portfolio Launch to OB/GYNs Globe Newswire 9:00 AM

-- October 14, 2026 --

Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control Globe Newswire 9:00 AM

-- October 8, 2026 --

Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo Globe Newswire 9:00 AM

-- September 15, 2026 --

Femasys Advances OB/GYN Expansion with Adoption of FemaSeed Fertility Portfolio by Minnesota Women's Care Globe Newswire 9:00 AM

-- September 9, 2026 --

Femasys Partners with CapexMD to Expand Patient Access to FemaSeed Fertility Portfolio Globe Newswire 9:00 AM

-- August 26, 2026 --

Femasys Partners with UNC Health to Introduce Its FemaSeed Fertility Portfolio Across Statewide OB/GYN Care Locations Globe Newswire 9:00 AM

-- August 19, 2026 --

Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc Globe Newswire 9:00 AM

-- August 14, 2026 --

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update Globe Newswire 4:05 PM

-- August 12, 2026 --

Femasys Strengthens and Extends Global Patent Protection for FemBloc with First Issued Blended Polymer Patents Globe Newswire 9:00 AM

-- August 7, 2026 --

Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million Globe Newswire 9:25 AM

-- June 24, 2026 --

Femasys Regains Compliance with Nasdaq Listing Requirements Globe Newswire 9:00 AM

Market Data Delayed 15 Minutes